NCT04824911View on ClinicalTrials.gov

Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

376

Participants

Timeline

Start Date

March 23, 2021

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions

Acute StrokeDual Antiplatelet TherapyStatin

Interventions

DRUG

Clopidogrel

300mg loading and 75mg/day from day 2

DRUG

Aspirin

Aspirin(100-300mg/day)

DRUG

Atorvastatin

Atorvastatin 40-80mg/day

DRUG

Rosuvastatin

Rosuvastatin 20 mg/day.

Trial Locations (1)

613

Yenchu Huang, Chiayi City

All Listed Sponsors

lead

Chang Gung Memorial Hospital

OTHER

NCT04824911 - Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease | Biotech Hunter | Biotech Hunter